Sunshine Biopharma Inc. Debt Instrument, Increase (Decrease), Other, Net
Sunshine Biopharma Inc. (SBFM) reported Debt Instrument, Increase (Decrease), Other, Net of $324.77 thousand for the 6-month period ending 2020-06-30, per its 10-Q/A filed 2020-08-31.
Discontinued › Notes › Debt › Debt Instruments › Debt Instrument, Increase (Decrease), Net
us-gaap:DebtInstrumentIncreaseDecreaseOtherNet · last filed 2020-08-31
- Sunshine Biopharma Inc. debt instrument, increase (decrease), other, net for the quarter ending 2020-06-30 was $391.27K.
- Sunshine Biopharma Inc. debt instrument, increase (decrease), other, net for the quarter ending 2020-03-31 was -$66.50K.
| Period end | Debt Instrument, Increase (Decrease), Other, Net 3 month | Debt Instrument, Increase (Decrease), Other, Net 6 month | Debt Instrument, Increase (Decrease), Other, Net 6 month as first filed | Debt Instrument, Increase (Decrease), Other, Net 9 month |
|---|---|---|---|---|
| 2020-06-30 | $391.27K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $324.77K 10-Q/A · filed 2020-08-31 | $230.07K 10-Q · filed 2020-08-19 | |
| 2020-03-31 | -$66.50K 10-Q · filed 2020-05-18 | |||
| 2019-09-30 | $241.16K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |